Sales Of Nerve Repair And Regeneration Devices Are Set To Increase At 11% CAGR Through 2026

 As per an in-depth industry analysis by Fact.MR, a market research and competitive intelligence provider, global demand for nerve repair and regeneration devices is expected to reach a valuation of US$ 12 billion by 2026, rising at a high CAGR of 11% over the forecast period (2022–2026).

The ageing population, which is more prone to neurological illnesses, and the rise in nerve injuries, are factors fueling market growth. Hospitals, ambulatory surgery centers, and other healthcare institutions across the world are providing innovative solutions for the fast diagnosis and treatment of neurological disorders. Through nerve repair and regeneration, damaged neural tissue, cells, and cellular byproducts can be replaced.

Request a Sample Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=7585?PS

New companies are concentrating on the development and commercialization of implantable solutions to enhance the effectiveness of peripheral nerve restoration surgeries.

New market entrants are engaged in introducing nerve regeneration supplements and nerve repair medicines to speed up healing and improve health after nerve injury.

• Renerva is an innovative medical device start-up based in the U.S. that joined Cornell University’s McGovern Center life sciences business. Renerva is developing an over-the-counter nerve transplant product that could prevent individuals from suffering from permanent disability and improving an injectable gel to speed up the regeneration of damaged nerves.

 

Key Segments Covered in the Nerve Repair and Regeneration Industry Survey

By Product :

• Neurostimulation & Neuromodulation Devices
• Biomaterials

 

By Application :

• Neurostimulation & Neuromodulation Surgeries
• Neurorrhaphy
• Nerve Grafting
• Stem Cell Therapy

 

By End User :

• Hospitals
• Clinics
• Ambulatory Surgery Centers

 

By Region :

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

 

Competitive Landscape

Key companies are investing in R&D operations to create innovative devices and ways to give patients up-to-date, accurate treatment. In the market for nerve repair and regeneration, these strategies are supporting manufacturers in securing a dominant position and extending their global reach. Development of the market for nerve repair and regeneration also highly depends on strategic alliances.

For instance,

• Scientists at the Mayo Clinic are developing a cell-based treatment for the neurodegenerative condition amyotrophic lateral sclerosis. They hope to do this by using a patient’s own adipose-derived mesenchymal stem cells, modifying them in a lab, and then reintroducing them into the person’s body.

 

Key players in the Nerve Repair and Regeneration Market

• Baxter
• Polyganics B.V.
• Nevro
• Stryker
• Abbott Laboratories
• AxoGen, Inc.
• Boston Scientific Corporation
• Integra LifeSciences Corporation
• LivaNova, PLC

 

Key Takeaways from Nerve Repair and Regeneration Market Study

• Global nerve repair and regeneration market to reach valuation of US$ 12 billion by 2026.
• Market in Canada expected to rise at 9% CAGR from 2022 to 2026.
• Market in Germany set to expand at 9.5% CAGR over the forecast period.
• Demand for neurostimulation & neuromodulation devices projected to rise at 9.5% CAGR through 2026.

 

Read More: https://www.factmr.com/report/nerve-repair-and-regeneration-market